State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.79B |
| 2 |
Truist Financial
TFC
|
+$1.36B |
| 3 |
Alibaba
BABA
|
+$1.05B |
| 4 |
ServiceNow
NOW
|
+$945M |
| 5 |
Las Vegas Sands
LVS
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.96B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$1.4B |
| 3 |
Cummins
CMI
|
+$607M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$414M |
| 5 |
RTX Corp
RTX
|
+$402M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Financials | 15.11% |
| 3 | Healthcare | 13.45% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Target Hospitality
TH
$1.43B
| $3M | ﹤0.01% |
600,655
+29,817
| +5% | +$157K |
|
2977
DHI Group
DHX
$177M
| $3M | ﹤0.01% |
997,104
+13,866
| +1% | +$47.1K |
|
|
ACOR
2978
DELISTED
Acorda Therapeutics
ACOR
| $3M | ﹤0.01% |
12,242
+462
| +4% | +$117K |
|
|
DLA
2979
DELISTED
Delta Apparel Inc.
DLA
| $3M | ﹤0.01% |
96,324
+12,984
| +16% | +$348K |
|
2980
Pampa Energía
PAM
$4.58B
| $2.99M | ﹤0.01% |
182,114
-1,536,510
| -89% | -$23.3M |
|
2981
Universal Logistics Holdings
ULH
$394M
| $2.99M | ﹤0.01% |
156,679
+8,858
| +6% | +$185K |
|
2982
AstraZeneca
AZN
$271B
| $2.98M | ﹤0.01% |
29,847
-72,903
| -71% | -$6.86M |
|
|
CHMA
2983
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $2.97M | ﹤0.01% |
598,524
+62,049
| +12% | +$323K |
|
|
TREC
2984
DELISTED
Trecora Resources
TREC
| $2.96M | ﹤0.01% |
414,593
+16,166
| +4% | +$132K |
|
|
LITS
2985
Lite Strategy Inc
LITS
$32.8M
| $2.96M | ﹤0.01% |
59,691
+5,530
| +10% | +$206K |
|
|
ATHX
2986
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.95M | ﹤0.01% |
95,925
+2,636
| +3% | +$86.4K |
|
|
NAGE
2987
Niagen Bioscience
NAGE
$252M
| $2.94M | ﹤0.01% |
682,298
+81,755
| +14% | +$291K |
|
|
CASI
2988
DELISTED
CASI Pharmaceuticals
CASI
| $2.94M | ﹤0.01% |
95,133
+7,619
| +9% | +$247K |
|
2989
AXT Inc
AXTI
$2.57B
| $2.94M | ﹤0.01% |
675,080
+25,021
| +4% | +$80.3K |
|
2990
CRISPR Therapeutics
CRSP
$4.65B
| $2.93M | ﹤0.01% |
48,052
+10,949
| +30% | +$598K |
|
2991
Talphera
TLPH
$67.5M
| $2.92M | ﹤0.01% |
69,290
-889
| -1% | -$36.3K |
|
|
PZN
2992
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.91M | ﹤0.01% |
337,104
+19,109
| +6% | +$165K |
|
|
TCRR
2993
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $2.9M | ﹤0.01% |
203,352
+36,718
| +22% | +$568K |
|
2994
Arcos Dorados Holdings
ARCO
$1.76B
| $2.9M | ﹤0.01% |
368,320
+25,826
| +8% | +$186K |
|
|
CLPR
2995
Clipper Realty
CLPR
$46.7M
| $2.9M | ﹤0.01% |
273,888
+25,530
| +10% | +$244K |
|
2996
American Superconductor
AMSC
$1.33B
| $2.89M | ﹤0.01% |
368,287
-11,756
| -3% | -$94.7K |
|
|
MR
2997
DELISTED
Montage Resources Corporation Common Stock
MR
| $2.89M | ﹤0.01% |
363,709
-42,487
| -10% | -$222K |
|
|
SNP
2998
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $2.88M | ﹤0.01% |
47,848
-269
| -0.6% | -$15.6K |
|
|
FPRX
2999
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.88M | ﹤0.01% |
626,555
-36,804
| -6% | -$146K |
|
|
FCCY
3000
DELISTED
1st Constitution Bancorp
FCCY
| $2.87M | ﹤0.01% |
129,810
+12,521
| +11% | +$250K |
|
Similar funds
State Street's Q4 2019 Portfolio in Review
As of Q4 2019, State Street held 3,899 positions worth $1.46T, up 8.8% from $1.34T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.8%. State Street opened 94 new positions and exited 92, leaving the 3,899-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 98,000 shares worth $114M.
- State Street added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.79B increase.
- State Street's biggest Q4 2019 reduction was Cummins, cutting an estimated $607M.
- State Street fully exited Celgene Corp in Q4 2019, selling an estimated $2.96B.
- State Street's ten largest holdings make up 18% of its $1.46T portfolio in Q4 2019.
- State Street opened 94 new positions and closed 92 in Q4 2019.
- State Street's portfolio value rose 8.8% quarter-over-quarter to $1.46T.
Based on State Street's 13F filing for Q4 2019, filed 6 Feb 2020.